Physician profile
Jesse Terrell
NPI 1578143715
$2,086.14
in general payments reported to CMS, 2019-2025
9 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $109 · 2023: $305 · 2024: $240 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $790.18 | 2022-2025 | Clareon, Hydrus Microstent, Unity |
| Glaukos Corporation | $581.33 | 2025 | Idosetr, Istent Infinite |
| Bausch & Lomb Americas INC. | $152.96 | 2022-2024 | Vyzulta, Stellaris |
| New World Medical,INC. | $138.56 | 2025 | Ahmed Glaucoma Valve, Via360, Clearpath |
| Rxsight INC | $127.39 | 2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec USA, INC. | $120.30 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $112.10 | 2024 | Eylea Hd |
| Abbvie INC. | $38.09 | 2024 | |
| Sight Sciences, INC. | $25.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.